159 related articles for article (PubMed ID: 36146724)
1. SARS-CoV-2 Infections in Vaccinated and Unvaccinated Populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022.
Arnold CE; Voegtly LJ; Stefanov EK; Lueder MR; Luquette AE; Miller RH; Miner HL; Bennett AJ; Glang L; McGinnis TN; Reisinger KE; Dugan JW; Mangat MA; Silberger DJ; Pavlicek RL; Watters CM; Rice GK; Malagon F; Cer RZ; Eggan SM; Bishop-Lilly KA
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146724
[TBL] [Abstract][Full Text] [Related]
2. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021.
Sarwar MB; Yasir M; Alikhan NF; Afzal N; de Oliveira Martins L; Le Viet T; Trotter AJ; Prosolek SJ; Kay GL; Foster-Nyarko E; Rudder S; Baker DJ; Muntaha ST; Roman M; Webber MA; Shafiq A; Shabbir B; Akram J; Page AJ; Jahan S
Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846280
[TBL] [Abstract][Full Text] [Related]
4. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
Front Public Health; 2022; 10():915363. PubMed ID: 35859775
[TBL] [Abstract][Full Text] [Related]
5. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021.
Marques AD; Sherrill-Mix S; Everett JK; Reddy S; Hokama P; Roche AM; Hwang Y; Glascock A; Whiteside SA; Graham-Wooten J; Khatib LA; Fitzgerald AS; Moustafa AM; Bianco C; Rajagopal S; Helton J; Deming R; Denu L; Ahmed A; Kitt E; Coffin SE; Newbern C; Mell JC; Planet PJ; Badjatia N; Richards B; Wang ZX; Cannuscio CC; Strelau KM; Jaskowiak-Barr A; Cressman L; Loughrey S; Ganguly A; Feldman MD; Collman RG; Rodino KG; Kelly BJ; Bushman FD
mBio; 2021 Feb; 13(1):e0378821. PubMed ID: 35130727
[TBL] [Abstract][Full Text] [Related]
7. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
[TBL] [Abstract][Full Text] [Related]
8. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
[TBL] [Abstract][Full Text] [Related]
9. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.
Islam OK; Al-Emran HM; Hasan MS; Anwar A; Jahid MIK; Hossain MA
Transbound Emerg Dis; 2021 Mar; 68(2):824-832. PubMed ID: 32701194
[TBL] [Abstract][Full Text] [Related]
10. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
11. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
[TBL] [Abstract][Full Text] [Related]
13. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
14. Genomic Characterization of SARS-CoV-2 Variants from Clinical Isolates during the COVID-19 Epidemic in Mauritania.
Deida J; Papa Mze N; Beye M; Ahmed SM; El Bara A; Bollahi MA; Basco L; Ould Mohamed Salem Boukhary A; Fournier PE
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540420
[TBL] [Abstract][Full Text] [Related]
15. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
[TBL] [Abstract][Full Text] [Related]
16. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.
Shetty A; Chatterjee G; Rajpal S; Srivastava T; Gardi N; Mirgh S; Gokarn A; Punatar S; Shetty N; Joshi A; Nair S; Murthy V; Khattry N; Tembhare P; Dikshit R; Chaturvedi P; More A; Kamtalwar S; Chavan P; Bhat V; Patil A; Dhumal S; Bhat P; Subramanian P; Gujral S; Badwe R; Patkar N; Gupta S
Int J Clin Pract; 2022; 2022():2449068. PubMed ID: 35685574
[TBL] [Abstract][Full Text] [Related]
17. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.
Di Giacomo S; Mercatelli D; Rakhimov A; Giorgi FM
J Med Virol; 2021 Sep; 93(9):5638-5643. PubMed ID: 33951211
[TBL] [Abstract][Full Text] [Related]
18. Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021.
Molina-Mora JA; Reales-González J; Camacho E; Duarte-Martínez F; Tsukayama P; Soto-Garita C; Brenes H; Cordero-Laurent E; Ribeiro Dos Santos A; Guedes Salgado C; Santos Silva C; Santana de Souza J; Nunes G; Negri T; Vidal A; Oliveira R; Oliveira G; Muñoz-Medina JE; Salas-Lais AG; Mireles-Rivera G; Sosa E; Turjanski A; Monzani MC; Carobene MG; Remes Lenicov F; Schottlender G; Fernández Do Porto DA; Kreuze JF; Sacristán L; Guevara-Suarez M; Cristancho M; Campos-Sánchez R; Herrera-Estrella A
Front Public Health; 2023; 11():1095202. PubMed ID: 36935725
[TBL] [Abstract][Full Text] [Related]
19. Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
Ntoumi F; Mfoutou Mapanguy CC; Tomazatos A; Pallerla SR; Linh LTK; Casadei N; Angelov A; Sonnabend M; Peter S; Kremsner PG; Velavan TP
Int J Infect Dis; 2021 Apr; 105():735-738. PubMed ID: 33737129
[TBL] [Abstract][Full Text] [Related]
20. Global SARS-CoV-2 genomic surveillance: What we have learned (so far).
Tosta S; Moreno K; Schuab G; Fonseca V; Segovia FMC; Kashima S; Elias MC; Sampaio SC; Ciccozzi M; Alcantara LCJ; Slavov SN; Lourenço J; Cella E; Giovanetti M
Infect Genet Evol; 2023 Mar; 108():105405. PubMed ID: 36681102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
